Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer

被引:27
作者
Suzuki, Hiroyuki [1 ]
Onishi, Hideya [1 ]
Morisaki, Takashi [2 ]
Tanaka, Masao [3 ]
Katano, Mitsuo [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Canc Therapy & Res, Fukuoka 8128582, Japan
[2] Fukuoka Gen Canc Clin, Fukuoka, Japan
[3] Kyushu Univ, Dept Surg & Oncol, Fukuoka 8128582, Japan
关键词
Vascular endothelial growth factor receptor2; Regulatory T cells; Colorectal cancer; Disease free survival; Overall survival; HEPATOCELLULAR-CARCINOMA; TUMOR MICROENVIRONMENT; OVARIAN-CANCER; PROGNOSIS; IDENTIFICATION; PROGRESSION; PREVALENCE;
D O I
10.1016/j.clim.2012.10.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previously, we have shown that CD8(+)T/FOXP3(+) cell ratio but not FOXP3(+) cell number alone is an independent prognostic factor for colorectal cancer. In the present study, we evaluated whether the number of intratumoral FOXP3(+)VEGFR2(+) (itFOXP3(+)VEGFR2(+)) T cells alone could be a predictive factor for survival prognosis in patients with colorectal cancer. Distribution of regulatory T cells (Tregs) at tumor sites derived from 88 patients with primary colorectal cancer was fluorescence-immunohistochemically examined. Relatively low number of itFOXP3(+)VEGFR2(+) cells significantly correlated with poor disease-free survival (DS) and overall survival (OS); multivariate analysis indicated that number of itFOXP3(+)VEGFR2(+) cells is an independent predictive and prognostic factor of DS and OS while neither intratumoral FOXP3(+) cell number nor intratumoral FOXP3(+)VEGFR2(-) cell number alone showed significant correlation with DS or OS. These results suggest that FOXP3(+)VEGFR2(+) may be a better predictive Treg marker than FOXP3(+) alone for recurrence and survival in patients with colorectal cancer. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 23 条
  • [11] Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
    Liyanage, UK
    Moore, TT
    Joo, HG
    Tanaka, Y
    Herrmann, V
    Doherty, G
    Drebin, JA
    Strasberg, SM
    Eberlein, TJ
    Goedegebuure, PS
    Linehan, DC
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (05) : 2756 - 2761
  • [12] In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
    Loddenkemper, Christoph
    Schernus, Martin
    Noutsias, Michel
    Stein, Harald
    Thiel, Eckhard
    Nagorsen, Dirk
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2006, 4 (1)
  • [13] Regulatory T cells in the control of immune pathology
    Maloy, KJ
    Powrie, F
    [J]. NATURE IMMUNOLOGY, 2001, 2 (09) : 816 - 822
  • [14] VEGF as a Mediator of tumor-associated immunodeficiency
    Ohm, JE
    Carbone, DP
    [J]. IMMUNOLOGIC RESEARCH, 2001, 23 (2-3) : 263 - 272
  • [15] Effector memory T cells, early metastasis, and survival in colorectal cancer
    Pagès, F
    Berger, A
    Camus, M
    Sanchez-Cabo, F
    Costes, A
    Molidor, R
    Mlecnik, B
    Kirilovsky, A
    Nilsson, M
    Damotte, D
    Meatchi, T
    Bruneval, P
    Cugnenc, PH
    Trajanoski, Z
    Fridman, WH
    Galon, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) : 2654 - 2666
  • [16] Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy
    Peggs, Karl S.
    Quezada, Sergio A.
    Allison, James P.
    [J]. IMMUNOLOGICAL REVIEWS, 2008, 224 : 141 - 165
  • [17] CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies -: Possible involvement of regulatory T cells in disease progression
    Sasada, T
    Kimura, M
    Yoshida, Y
    Kanai, M
    Takabayashi, A
    [J]. CANCER, 2003, 98 (05) : 1089 - 1099
  • [18] Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
    Sato, E
    Olson, SH
    Ahn, J
    Bundy, B
    Nishikawa, H
    Qian, F
    Jungbluth, AA
    Frosina, D
    Gnjatic, S
    Ambrosone, C
    Kepner, J
    Odunsi, T
    Ritter, G
    Lele, S
    Chen, YT
    Ohtani, H
    Old, LJ
    Odunsi, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18538 - 18543
  • [19] Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
    Suzuki, Hiroyuki
    Chikazawa, Nobuhito
    Tasaka, Takehiko
    Wada, Junji
    Yamasaki, Akio
    Kitaura, Yoshiki
    Sozaki, Masae
    Tanaka, Masao
    Onishi, Hideya
    Morisaki, Takashi
    Katano, Mitsuo
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (05) : 653 - 661
  • [20] VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
    Suzuki, Hiroyuki
    Onishi, Hideya
    Wada, Junji
    Yamasaki, Akio
    Tanaka, Haruo
    Nakano, Kenji
    Morisaki, Takashi
    Katano, Mitsuo
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (01) : 197 - 203